Drugplain

AFSTYLA Antihemophilic Factor (Recombinant), Single Chain

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT · KIT · CSL Behring Lengnau AG

No Recall History
Plain English

AFSTYLA Antihemophilic Factor (Recombinant), Single Chain is a kit containing antihemophilic factor, human recombinant. Manufactured by CSL Behring Lengnau AG.

Key Facts

Brand Name
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
Generic Name
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
NDC Code (Product)
69911-474
Manufacturer
CSL Behring Lengnau AG
Dosage Form
KIT
Marketing Status
Application #
BLA125591
Marketing Start
05/25/2016

Recall History

No Recall History

Frequently Asked Questions

What is AFSTYLA Antihemophilic Factor (Recombinant), Single Chain used for?

AFSTYLA Antihemophilic Factor (Recombinant), Single Chain contains ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT. It is a kit taken as directed. Consult your doctor for specific uses.

Is AFSTYLA Antihemophilic Factor (Recombinant), Single Chain a controlled substance?

AFSTYLA Antihemophilic Factor (Recombinant), Single Chain is not classified as a controlled substance by the DEA.

What is the generic name for AFSTYLA Antihemophilic Factor (Recombinant), Single Chain?

The generic name for AFSTYLA Antihemophilic Factor (Recombinant), Single Chain is ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT. There are no other listed brand versions of ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT.

What is the NDC code for AFSTYLA Antihemophilic Factor (Recombinant), Single Chain ?

The NDC (National Drug Code) for AFSTYLA Antihemophilic Factor (Recombinant), Single Chain is 69911-474, listed by CSL Behring Lengnau AG.

Product NDC

69911-474

Package NDC

69911-474-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)